Neurocrine

Action

ISIN: US64125C1099

Ticker: NBIX

US64125C1099

NBIX

Price

Discussion sur NBIX

Postes

But T.

@But_the_Stock_Picked_Me

4Sem.·

$NBIX (+1,11 %)
$REGN (-0,32 %) Is there anyone here who is invested in Neurocrine or Regeneron?

The shares seem to be attractively priced at the moment and the companies appear to be financially sound. However, I'm not that familiar with the sector yet.

I would therefore be grateful for any opinions.

10 Commentaires

Memo0606@Memo0606

4Sem.

@Tenbagger2024 $REGN something for us? 🤩🥶

••

Voir toutes les 8 autres réponses

DJJD

@DJJOSE

4Mo·

$NBIX (+1,11 %)

Neurocrine Biosciences (NASDAQ:NBIX) said the FDA has accepted its two new drug applications for priority review for its drug crinecerfont in the treatment of pediatric and adult patients with congenital adrenal hyperplasia, a rare endocrine disorder.

https://seekingalpha.com/news/4121247-fda-sets-target-action-dates-for-neurocrine-drug-applications

Titres populaires

Meilleurs créateurs cette semaine